Niagen Bioscience (NAGE) Asset Utilization Ratio (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Asset Utilization Ratio data on file, last reported at 1.18 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 18.09% year-over-year to 1.18 in Q1 2026; TTM through Mar 2026 was 1.18, a 18.09% decrease from a year earlier, with the FY2025 full-year figure at 1.48, down 8.32% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 1.18, down from 1.27 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for NAGE reached as high as 1.66 in Q3 2024 and fell as low as 1.18 in Q1 2026.
• Historically, Asset Utilization Ratio has averaged 1.44 across 5 years, with a median of 1.45 in 2022.
• Across the five-year window, Asset Utilization Ratio jumped 44.59% in 2022 and fell 20.72% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 1.45 in 2022, then climbed by 6.66% to 1.54 in 2023, then rose by 3.56% to 1.6 in 2024, then slipped by 20.72% to 1.27 in 2025, then decreased by 6.62% to 1.18 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 1.18 in Q1 2026, 1.27 in Q4 2025, and 1.32 in Q3 2025.